FDA Inspection
Marksans Pharma LimitedMarksans Pharma Limited – FDA Inspection, Mar 6, 2019
Record Details
This FDA Inspection record concerns Marksans Pharma Limited, with an inspection on March 6, 2019, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 89c41cd9-6d6a-41af-b1e2-3bcf8b53dc1d
Inspection Facts
- Inspection number
- 1086017
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Marksans Pharma Limited
6| Date | Classification | Office | Project area |
|---|---|---|---|
| April 17, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 4, 2023 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| April 7, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 3, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 3, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Marksans Pharma Limited
- FDA Inspection 1236614 - 2024-04-17
- FDA Inspection 1211415 - 2023-08-04
- FDA Inspection 1014460 - 2017-04-07
- FDA Inspection 944722 - 2015-09-03
- FDA Inspection 795367 - 2012-08-03
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.